DE2333740C2 - Verwendung eines Hämagglutinations-Hemmverfahrens zur Ermittlung von Krebs - Google Patents

Verwendung eines Hämagglutinations-Hemmverfahrens zur Ermittlung von Krebs

Info

Publication number
DE2333740C2
DE2333740C2 DE2333740A DE2333740A DE2333740C2 DE 2333740 C2 DE2333740 C2 DE 2333740C2 DE 2333740 A DE2333740 A DE 2333740A DE 2333740 A DE2333740 A DE 2333740A DE 2333740 C2 DE2333740 C2 DE 2333740C2
Authority
DE
Germany
Prior art keywords
antigen
capa
samples
cancer
predetermined amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2333740A
Other languages
German (de)
English (en)
Other versions
DE2333740A1 (de
Inventor
Knut Dr.med. Bromma Bertil
Original Assignee
Aktiebolaget Bonnierföretagen, Stockholm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktiebolaget Bonnierföretagen, Stockholm filed Critical Aktiebolaget Bonnierföretagen, Stockholm
Publication of DE2333740A1 publication Critical patent/DE2333740A1/de
Application granted granted Critical
Publication of DE2333740C2 publication Critical patent/DE2333740C2/de
Expired legal-status Critical Current

Links

Classifications

    • G01N33/5758—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE2333740A 1972-07-10 1973-07-03 Verwendung eines Hämagglutinations-Hemmverfahrens zur Ermittlung von Krebs Expired DE2333740C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27027372A 1972-07-10 1972-07-10

Publications (2)

Publication Number Publication Date
DE2333740A1 DE2333740A1 (de) 1974-01-31
DE2333740C2 true DE2333740C2 (de) 1987-01-22

Family

ID=23030635

Family Applications (2)

Application Number Title Priority Date Filing Date
DE2333740A Expired DE2333740C2 (de) 1972-07-10 1973-07-03 Verwendung eines Hämagglutinations-Hemmverfahrens zur Ermittlung von Krebs
DE2366609A Expired DE2366609C2 (OSRAM) 1972-07-10 1973-07-03

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE2366609A Expired DE2366609C2 (OSRAM) 1972-07-10 1973-07-03

Country Status (22)

Country Link
JP (2) JPS5817168B2 (OSRAM)
AR (1) AR197243A1 (OSRAM)
AT (1) AT336780B (OSRAM)
BE (1) BE802126A (OSRAM)
BR (1) BR7305142D0 (OSRAM)
CA (1) CA1039650A (OSRAM)
CH (1) CH617853A5 (OSRAM)
DD (2) DD113918A5 (OSRAM)
DE (2) DE2333740C2 (OSRAM)
DK (1) DK139898B (OSRAM)
ES (1) ES416726A1 (OSRAM)
FI (1) FI60567C (OSRAM)
FR (1) FR2191885B1 (OSRAM)
GB (2) GB1443054A (OSRAM)
IL (1) IL42594A (OSRAM)
IN (1) IN138903B (OSRAM)
IT (1) IT1009527B (OSRAM)
NL (1) NL7309257A (OSRAM)
NO (1) NO146338C (OSRAM)
SE (3) SE440697B (OSRAM)
SU (1) SU581842A3 (OSRAM)
ZA (1) ZA734632B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
JPS56145297A (en) * 1980-04-11 1981-11-11 Kureha Chem Ind Co Ltd Preparative method of glycoprotein having immunosupressing activity
GB2121417A (en) * 1982-02-22 1983-12-21 Carlton Med Prod Antigens and antibodies useful in the detection of cancer

Also Published As

Publication number Publication date
NO146338B (no) 1982-06-01
SE440597B (sv) 1985-08-12
GB1443053A (en) 1976-07-21
SE418186B (sv) 1981-05-11
SE440697B (sv) 1985-08-12
DE2333740A1 (de) 1974-01-31
FR2191885A1 (OSRAM) 1974-02-08
IL42594A (en) 1976-08-31
FR2191885B1 (OSRAM) 1977-07-01
IN138903B (OSRAM) 1976-04-10
SE7609837L (sv) 1976-09-06
IT1009527B (it) 1976-12-20
JPS5817168B2 (ja) 1983-04-05
SU581842A3 (ru) 1977-11-25
CA1039650A (en) 1978-10-03
JPS6018011B2 (ja) 1985-05-08
SE7609836L (sv) 1976-09-06
DK139898B (da) 1979-05-14
ATA600773A (de) 1976-09-15
IL42594A0 (en) 1973-08-29
FI60567C (fi) 1982-02-10
AU5728673A (en) 1975-01-09
JPS56115954A (en) 1981-09-11
AT336780B (de) 1977-05-25
DD118946A5 (OSRAM) 1976-03-20
ES416726A1 (es) 1976-06-16
NO146338C (no) 1982-09-08
NL7309257A (OSRAM) 1974-01-14
AR197243A1 (es) 1974-03-22
BE802126A (fr) 1973-11-05
BR7305142D0 (pt) 1974-08-22
DD113918A5 (OSRAM) 1975-07-05
JPS4955823A (OSRAM) 1974-05-30
DK139898C (OSRAM) 1979-10-08
FI60567B (fi) 1981-10-30
GB1443054A (en) 1976-07-21
ZA734632B (en) 1974-06-26
DE2366609C2 (OSRAM) 1988-02-25
CH617853A5 (en) 1980-06-30

Similar Documents

Publication Publication Date Title
US4160018A (en) Stabilized cancer associated polypeptide antigen and preparation thereof
CH658317A5 (de) Verfahren zur feststellung von krebs beim menschen.
CH634334A5 (de) Neues glycoprotein und verfahren zu dessen herstellung.
EP0060491B1 (de) Protein (PP16), Verfahren zu seiner Anreicherung und Gewinnung sowie seine Verwendung
EP0101063B1 (de) Neues Polypeptid mit Wirkung auf das Immunsystem, Verfahren zu seiner Isolierung und Reinigung, seine Verwendung und dieses enthaltende Mittel
US4211766A (en) Cancer associated polypeptide antigen compositions
Sellers et al. An electrophoretic study of urinary protein in the rat
DE1949195A1 (de) Verfahren zur Herstellung deproteinisierter Bluextrakte mit Heilwirkung
DE2745237A1 (de) Mittel zur immunisierung und zum nachweis von speziellen krebsarten
DE2333740C2 (de) Verwendung eines Hämagglutinations-Hemmverfahrens zur Ermittlung von Krebs
DE68911693T2 (de) Pharmazeutisches mittel für behandlung von menschlichem krebs und verfahren zu seiner herstellung.
DE69731891T2 (de) Verfahren zur reinigung von gbs-toxin/cm101
Franklin et al. Comparison of honeybee venoms and their components from various sources
DE3306944C2 (OSRAM)
RU2033796C1 (ru) Пептидсодержащая фракция из селезенки млекопитающих, обладающая иммуностимулирующей активностью и способ ее получения
DE2043971C3 (de) Antitumorsubstanz aus haemolytischen Streptococcen
DE2814121C3 (de) Verfahren zur Herstellung eines bei der Krebs-Diagnose verwendbaren spezifischen Immunserums K K Saikin Kagaku Kenkyujo, Sendaishi
DE2515666C3 (de) Piasminreiche Gammaglobulinfraktion, Verfahren zu deren Herstellung und das Verfahrensprodukt enthaltendes Gammaglobulinpräparat
DE1617332A1 (de) Verfahren zur Isolierung eines Proteins
DE2062558A1 (de) Mittel zur Diagnose von primärem Leberkrebs und Verfahren zur Her stellung desselben
AT293611B (de) Verfahren zur Feststellung von neoplastischem Zellmaterial
DE2815758C3 (de) Peptidkomplexe aus DNS-haltigen Organismen
Westphal et al. Azorubin-binding capacity and protein composition of serum of rats subjected to tourniquet shock and to treatment with carbon tetrachloride
DE2630380A1 (de) Verfahren zur herstellung einer vakzine
EP0107782A1 (de) Verfahren zur Isolierung von Relaxin

Legal Events

Date Code Title Description
OGA New person/name/address of the applicant
OD Request for examination
8125 Change of the main classification

Ipc: G01N 33/54

8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 2366609

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 2366609

D2 Grant after examination
8364 No opposition during term of opposition
AH Division in

Ref country code: DE

Ref document number: 2366609

Format of ref document f/p: P